About 23Mofang
23Mofang is a company based in Chengdu (China) founded in 2015. 23Mofang has raised $34.25 million across 5 funding rounds from investors including Hanwang, CD Capital and SBCVC. 23Mofang operates in a competitive market with competitors including CircleDNA, WeGene, GeseDNA, Aijiyin and 1JKT, among others.
- Headquarter Chengdu, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$34.25 M (USD)
in 5 rounds
-
Latest Funding Round
$9.65 M (USD), Series B
May 31, 2018
-
Investors
Hanwang
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of 23Mofang
23Mofang has successfully raised a total of $34.25M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $9.65 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 23Mofang
23Mofang has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Hanwang, CD Capital and SBCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
China-based startups are invested in by SBCVC across diverse sectors.
|
Locked | Locked | Locked | |
|
Tech & Life Science focused early & growth stage VC firm investing in the US & China
|
Locked | Locked | Locked |
Investor details for 23Mofang
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 23Mofang
Investment portfolio details for 23Mofang
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 23Mofang
Detailed financials for 23Mofang
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
23Mofang Comparisons
Peer comparison for 23Mofang
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 23Mofang
23Mofang operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CircleDNA, WeGene, GeseDNA, Aijiyin and 1JKT, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Internet-first platform for genetic diagnostics is provided.
|
|
| Locked | Locked | Locked |
Genetic testing is conducted using saliva for health risk detection.
|
|
| Locked | Locked | Locked |
Gene detection tools and DNA interpretation services are provided.
|
|
| Locked | Locked | Locked |
Genetic testing solutions are offered via an online platform.
|
|
| Locked | Locked | Locked |
Online platform offering appointment booking services for genetic tests
|
Detailed competitors of 23Mofang
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 23Mofang
Complete news archive for 23Mofang
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 23Mofang
23Mofang was founded in 2015 and raised its 1st funding round 1 year after it was founded.
23Mofang is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
23Mofang is a funded company, having raised a total of $34.25M across 5 funding rounds to date.
23Mofang was founded in 2015 in Chengdu, China, within the genetic testing sector. Services are delivered to assess health risks and physical characteristics via genetic analysis. International quality control standards are followed, with global research data incorporated for genetic interpretation. Operations are based in China, supporting users in early health interventions and risk identification.
23Mofang has 9 investors. Key investors include Hanwang, CD Capital, SBCVC, 3E Bioventures Capital, and Matrix Partners China.